Instead of continuing at 12mg Retatrutide or 15mg Tirzepatide, maintenance at 4 to 8mg or 7.5 to 10mg respectively often proves sufficient
After: hiking three miles on a weekend without thinking twice about it
Slurred speech, dizziness
Safety Profile The most common adverse events documented across retatrutide results data were gastrointestinal in nature, with incidence increasing at higher doses: Nausea: 6-31% (dose-dependent), primarily during escalation periods Diarrhea: 6-25%, generally mild to moderate Vomiting: 0-16%, occurring mainly in the first weeks of each dose increase Decreased appetite: 3-19%, which contributed to the weight reduction effect Constipation: 3-12%, consistent with GLP-1 receptor-mediated gastric slowing Serious adverse events were rare across all cohorts
These medications are popular prescriptions in the U.S
While taking the medication, he suffered severe pain, which was related to a blood clot called a DVT)